San Francisco-based dispensary got flipped by three different owners in two months, including to High Times.
Cannabis companies are finally feeling like this is their moment to shine.
It's not something momentum traders would care about in the short-run, but if we do see a squeeze, don't be greedy.
Cannabis is looking like a true recession resistant item.
Cannabis beverages still remain at the bottom of the sales charts. The switch to cannabis hasn't saved the day yet for alcohol companies.
Here are the reversals I'm looking for on Monday on the SPDR S&P 500 exchange-traded fund trust.
This year the Covid-19 lockdown has killed the cannabis celebration buzz.
Studies appear to back up some cannabis products' use in helping users catch needed z's.
Several companies that had appeared promising are now blaming the Covid-19 crisis as they fail to turn over a new leaf for the better.
As crisis turns into one of mental health as well as physical health, some firms are experimenting with use of LSD and 'magic mushroom' compounds.